CID 3043786

Salicylamide, n-((benzylcarbamoyl)methyl)-

Structural Information

Molecular Formula
C16H16N2O3
SMILES
C1=CC=C(C=C1)CNC(=O)CNC(=O)C2=CC=CC=C2O
InChI
InChI=1S/C16H16N2O3/c19-14-9-5-4-8-13(14)16(21)18-11-15(20)17-10-12-6-2-1-3-7-12/h1-9,19H,10-11H2,(H,17,20)(H,18,21)
InChIKey
YOXMSXDWRQZTRD-UHFFFAOYSA-N
Compound name
N-[2-(benzylamino)-2-oxoethyl]-2-hydroxybenzamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

284.1161 Da
Monoisotopic Mass

2.2
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 285.123376 164.9
[M+Na]+ 307.105318 169.2
[M-H]- 283.108824 169.9
[M+NH4]+ 302.149923 178.6
[M+K]+ 323.079258 165.6
[M+H-H2O]+ 267.113360 156.6
[M+HCOO]- 329.114301 188.1
[M+CH3COO]- 343.129951 201.8
[M+Na-2H]- 305.090766 169.1
[M]+ 284.11555142 163.2
[M]- 284.11664858 163.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.